Cerevel Therapeutics Holdings, Inc. (CERE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 7.43B |
| Enterprise Value | 7.12B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 27.22 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -17.94 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.38 |
| 52-Week Change 3 | 52.50% |
| S&P500 52-Week Change 3 | 15.38% |
| 52 Week High 3 | 41.75 |
| 52 Week Low 3 | 19.59 |
| 50-Day Moving Average 3 | 24.99 |
| 200-Day Moving Average 3 | 26.80 |
Share Statistics
| Avg Vol (3 month) 3 | 1.8M |
| Avg Vol (10 day) 3 | 6.44M |
| Shares Outstanding 5 | 180.28M |
| Implied Shares Outstanding 6 | 180.28M |
| Float 8 | 76.04M |
| % Held by Insiders 1 | 15.20% |
| % Held by Institutions 1 | 82.11% |
| Shares Short (Nov 14, 2023) 4 | 8.21M |
| Short Ratio (Nov 14, 2023) 4 | 9.04 |
| Short % of Float (Nov 14, 2023) 4 | 12.16% |
| Short % of Shares Outstanding (Nov 14, 2023) 4 | 4.55% |
| Shares Short (prior month Oct 12, 2023) 4 | 7.41M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2022 |
| Most Recent Quarter (mrq) | Sept 29, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -27.08% |
| Return on Equity (ttm) | -89.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -409.53M |
| Net Income Avi to Common (ttm) | -392.99M |
| Diluted EPS (ttm) | -2.50 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 676.88M |
| Total Cash Per Share (mrq) | 3.76 |
| Total Debt (mrq) | 473.44M |
| Total Debt/Equity (mrq) | 173.45% |
| Current Ratio (mrq) | 8.72 |
| Book Value Per Share (mrq) | 1.73 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -332.36M |
| Levered Free Cash Flow (ttm) | -193.15M |
© 2023 Yahoo. All rights reserved.